Medtronic PLC

Medtronic PLC Stock Forecast & Price Prediction

Live Medtronic PLC Stock (MDT) Price
$88.27

23

Ratings

  • Buy 11
  • Hold 12
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$88.27

P/E Ratio

29.68

Volume Traded Today

$2.9M

Dividend

$0.7

52 Week High/low

92.68/72.08

Medtronic PLC Market Cap

$113.07B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $MDT ๐Ÿ›‘

Before you buy MDT you'll want to see this list of ten stocks that have huge potential. Want to see if MDT made the cut? Enter your email below

MDT Summary

Based on ratings from 23 stock analysts, the Medtronic PLC stock price is expected to increase by 8.84% in 12 months. This is calculated by using the average 12-month stock price forecast for Medtronic PLC. The lowest target is $82 and the highest is $110.12. Please note analyst price targets are not guaranteed and could be missed completely.

MDT Analyst Ratings

About 23 Wall Street analysts have assignedMDT 11 buy ratings, 12 hold ratings, and 0 sell ratings. This means that analysts expect Medtronic PLC to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on MDT. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

MDT stock forecast by analyst

These are the latest 20 analyst ratings of MDT.

Analyst/Firm

Rating

Price Target

Change

Date

Mike Matson
Needham

Hold


Reiterates

Oct 25, 2024
Richard Newitter
Truist Securities

Hold

$93

Maintains

Oct 14, 2024
Shagun Singh
RBC Capital

Outperform

$105

Upgrade

Oct 10, 2024
Shagun Singh
RBC Capital

Sector Perform

$98

Maintains

Oct 8, 2024
Joanne Wuensch
Citigroup

Neutral

$92

Maintains

Oct 1, 2024
Vijay Kumar
Evercore ISI Group

Outperform

$104

Maintains

Oct 1, 2024
Richard Newitter
Truist Securities

Hold

$90

Maintains

Aug 23, 2024
Matt Miksic
Barclays

Overweight

$105

Maintains

Aug 22, 2024
Rick Wise
Stifel

Hold

$87

Maintains

Aug 21, 2024
Matt O'Brien
Piper Sandler

Neutral

$90

Maintains

Aug 21, 2024
Shagun Singh
RBC Capital

Sector Perform

$92

Reiterates

Aug 21, 2024
David Rescott
Baird

Neutral

$90

Maintains

Aug 21, 2024
Steven Lichtman
Oppenheimer

Perform

$94

Maintains

Aug 21, 2024
Larry Biegelsen
Wells Fargo

Overweight

$106

Maintains

Aug 21, 2024
Mike Matson
Needham

Hold


Reiterates

Aug 20, 2024
Danielle Antalffy
UBS

Neutral

$90

Upgrade

Aug 15, 2024
Rick Wise
Stifel

Hold

$85

Downgrade

Aug 14, 2024
Mike Matson
Needham

Hold


Reiterates

Aug 12, 2024
Shagun Singh
RBC Capital

Sector Perform

$92

Reiterates

Jul 17, 2024
Richard Newitter
Truist Securities

Hold

$85

Maintains

Jul 16, 2024

MDT Company Information

What They Do: Develops device-based medical therapies globally.

Business Model: The company generates revenue by designing, manufacturing, and selling a wide range of medical devices across various therapeutic areas, including cardiovascular, neuroscience, medical surgical, and diabetes care. By targeting healthcare systems, physicians, and patients, Medtronic creates value through innovative products that address critical health conditions, ensuring ongoing demand and market presence.

Other Information: Founded in 1949 and headquartered in Galway, Ireland, Medtronic has established itself as a leader in the medical technology industry. Its diverse product offerings and commitment to advancing healthcare solutions position the company for sustained growth and investment potential.
MDT
Medtronic PLC (MDT)

When did it IPO

1981

Staff Count

95,000

Country

Ireland

Sector/Industry

Healthcare/Medical Devices

CEO

Mr. Geoffrey Straub Martha

Market Cap

$113.07B

Medtronic PLC (MDT) Financial Data

In 2023, MDT generated $31.23B in revenue, which was a decrease of -1.45% from the previous year. This can be seen as a signal that MDT's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

$30.12B

0.00 %
From Previous Year

Revenue From 2022

$31.69B

5.21 %
From Previous Year

Revenue From 2023

$31.23B

-1.45 %
From Previous Year
  • Revenue TTM $32.58B
  • Operating Margin TTM 17.5%
  • Gross profit TTM $21.15B
  • Return on assets TTM 4.4%
  • Return on equity TTM 7.9%
  • Profit Margin 12.1%
  • Book Value Per Share 37.39%
  • Market capitalisation $113.07B
  • Revenue for 2021 $30.12B
  • Revenue for 2022 $31.69B
  • Revenue for 2023 $31.23B
  • EPS this year (TTM) $2.97

Medtronic PLC (MDT) Latest News

News Image

Mon, 11 Nov 2024

Sentiment - NEUTRAL

Source - Zacks Investment Research

Summary - Oracle, Micron Technology, Medtronic, and The Cato are highlighted in a recent analyst blog, potentially indicating investment opportunities or insights.

Why It Matters - Inclusion of Oracle, Micron Technology, Medtronic, and Cato in an analyst blog suggests potential investment opportunities or insights, possibly influencing stock performance and market sentiment.

News Image

Fri, 08 Nov 2024

Sentiment - NEGATIVE

Source - Zacks Investment Research

Summary - Medtronic (MDT) closed at $87.72, down 0.45% from the previous trading day.

Why It Matters - Medtronic's slight decline may indicate market concerns or shifting investor sentiment, potentially impacting future stock performance and investment strategies.

News Image

Tue, 05 Nov 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Medtronic plc (NYSE:MDT) will report its Q2 fiscal 2025 financial results on November 19, 2024, with a news release scheduled for 5:45 a.m. EST.

Why It Matters - Medtronic's upcoming financial results may impact its stock price and investor sentiment, signaling performance trends and potential growth or challenges in the healthcare sector.

News Image

Thu, 07 Nov 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - Medtronic's fiscal second-quarter profits may have been negatively affected by the current geopolitical situation, similar to other companies in the sector.

Why It Matters - Geopolitical tensions could negatively affect Medtronic's Q2 profits, signaling potential financial instability and impacting stock performance and investor confidence.

News Image

Wed, 06 Nov 2024

Sentiment - POSITIVE

Source - Benzinga

Summary - Investors often seek dividend-yielding stocks during market turbulence, as these companies typically have high free cash flows and provide substantial dividends.

Why It Matters - Dividend-yielding stocks provide stability and income during market volatility, appealing to investors seeking reliable returns and companies with strong cash flows.

News Image

Sat, 02 Nov 2024

Sentiment - POSITIVE

Source - The Motley Fool

Summary - The article highlights stocks that are considered stable and reliable, providing investors with peace of mind regarding their investments.

Why It Matters - Stocks identified as stable can reduce portfolio volatility, providing a sense of security and potential for steady returns, appealing to risk-averse investors.

...

MDT Frequently asked questions

The highest forecasted price for MDT is $110.12 from at .

The lowest forecasted price for MDT is $82 from from JP Morgan

The MDT analyst ratings consensus are 11 buy ratings, 12 hold ratings, and 0 sell ratings.